Oncogenic ras protein induces meiotic maturation of amphibian oocytes in the presence of protein synthesis inhibitors  by Allende, Catherine C. et al.
Volume 234, number 2, 426-430 FEB 06103 July 1988 
Oncogenic ras protein induces meiotic maturation of amphibian 
oocytes in the presence of protein synthesis inhibitors 
Catherine C. Allende*, M. Victoria Hinrichs”, Eugenio Santos and Jorge E. Allende” 
*Departamento de Biologia. Facultad de Ciencias, “Departamento de Bioquimica, Facultad de Medicina, Universidad de 
Chile, Santiago, Chile and Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Bethesda, MD 20892, USA 
Received 26 May 1988 
Microinjection of the activated ras oncogenic protein can induce the meiotic maturation of Xenopus luevis oocytes, a 
process that can also be triggered by progesterone or high concentrations of insulin. Cycloheximide and puromycin, well- 
known inhibitors of protein synthesis, block the maturation process induced by progesterone and insulin but do not affect 
the maturation caused by H-rus ‘ysn protein microinjection. Theophylline, an inhibitor of CAMP phosphodiesterase that 
also affects oocyte protein synthesis, does cause a partial inhibition of ras protein-induced maturation. These findings 
indicate that ras protein acts on the oocyte maturation process at a point that is downstream of the protein synthesis 
requirement, a characteristic shared with the maturation promoting factor, an activity that appears in oocytes and mitotic 
cells at the onset of cell division. 
Maturation; Protein-synthesis inhibitor; 0oc;te; ras protein 
1. INTRODUCTION 
Full-grown amphibian oocytes are arrested in 
the first meiotic prophase. Progesterone or high 
concentrations of insulin can induce these cells to 
progress to the second meiotic metaphase in a pro- 
cess that is known as meiotic maturation (review 
[ll). 
This process is very complex and shares many of 
the features of mitotic cell division. Some of the 
most relevant molecular events that have been 
found to occur in oocytes during progesterone- 
induced maturation are summarized below. 
(i) A transient decrease in CAMP is caused by the 
atypical inhibition of adenylate cyclase by pro- 
gesterone (review [2]). Inhibition of this decrease 
by activators of the adenylate cyclase such as 
cholera toxin or by theophylline prevents 
progesterone-induced maturation. Activation of 
CAMP-dependent protein kinase blocks matura- 
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tion while inhibitors of this activity induce the 
maturation process [3]. 
(ii) An increase (2-3-fold) in oocyte protein syn- 
thesis occurs 2 h after progesterone treatment and 
this is post-transcriptionally regulated [4]. In- 
hibitors of protein synthesis added up to 2 h after 
hormone treatment block maturation [5]. 
(iii) A maturation-promoting factor (MPF) is 
observed in the oocyte cytoplasm approx. 2-3 h 
after progesterone treatment. Microinjection of 
MPF causes rapid maturation of oocytes without 
exposure to hormone. The maturation caused by 
MPF cannot be blocked by protein synthesis in- 
hibitors. This factor has not been completely 
purified but partially purified preparations contain 
protein kinase activity. MPF appears during 
mitosis of many different eukaryotic cells and is 
functionally active in oocytes [6,7]. 
(iv) After MPF microinjection or 3-4 h after pro- 
gesterone treatment, there is a significant increase 
in oocyte protein phosphorylation [8]. Two pro- 
teins whose phosphorylation increases con- 
comitantly with maturation have been identified as 
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ribosomal protein S6 [9], and the nuclear 
nucleosome assembly factor, nucleoplasmin [lo]. 
In animal cells, the family of ra.s genes produces 
closely related p21 proteins that bind GTP and 
GDP and have intrinsic GTPase activity. Specific 
mutations activate their malignant potential and 
the resulting oncogenes code for p21 proteins that 
have transforming activity (review [ll]). The 
microinjection of the activated c-Harvey ras pro- 
tein induces maturation in Xenopus laevis oocytes 
more efficiently than the normal c-Harvey ras pro- 
tein [12]. 
Supporting evidence for the possible participa- 
tion of the endogenous ras protein in oocyte 
maturation has been obtained by microinjection of 
monoclonal antibodies that inactivate ras proteins. 
The presence of these antibodies inhibits the induc- 
tion of maturation by insulin but not that triggered 
by progesterone [13,14]. This has suggested that 
parallel pathways for meiotic maturation may be 
operative in the oocyte. Here, we demonstrate that 
the induction of oocyte maturation caused by 
microinjection of activated ras protein cannot be 
blocked by the inhibition of protein synthesis 
although insulin-caused maturation does require 
protein synthesis. 
2. MATERIALS AND METHODS 
Adult female X. luevis were obtained from Nasco (Fort 
Atkinson, WI) or the South African Animal Farm (Cape Town, 
South Africa). Both hormonally stimulated animals [7], which 
received by injection low levels of human chorionic 
gonadotropin (Sigma CG-10) and non-stimulated animals were 
used. Oocytes were removed surgically from animals anesthe- 
tized by hypothermia. Stage VI oocytes were hand-separated, 
into Barth solution (88 mM NaCl, 2.4 mM NaHCOs, 1 mM 
KCl, 0.82 mM MgSO+ 0.74 mM CaCl2,0.33 mM Ca(NO&, 10 
mM Tris-HCl, pH 7.6, and 10 pg/ml each of penicillin and 
streptomycin sulfate) and used the same day. For some ex- 
periments, KC1 was omitted from the saline solution. Removal 
of follicle cells by collagenase treatment (Sigma type 1A; 4 h at 
1.5 mg collagenase/ml Barth solution, followed by extensive 
rinsing) did not alter the response of oocytes to rus-induced 
maturation. 
Maturation was induced by the addition of 10 pM pro- 
gesterone (Sigma), 1 pM insulin (Miles) or by ras protein 
microinjection, using groups of about 30 oocytes. Controls 
were performed with the corresponding vehicle. Maturation in 
the presence of inhibitors was measured (without preincubation 
of the oocytes) at 20 ,uM cycloheximide, 500 gM puromycin or 
1 mM theophylline in Barth solution [S]. 
Maturation was scored, routinely after 8-10 h but occasional- 
ly at 18 h, by microscopic examination for the presence of the 
nucleus in the treated oocytes after fixation with 5% 
trichloroacetic acid. The absence of the nucleus indicated that 
‘germinal vesicle breakdown’ (GVBD) had occurred. In the 
oocytes microinjected with activated rus protein, the white spot 
in the pigmented animal pole that typifies GVBD was often 
larger and upon extended incubation (16-24 h) the pigmenta- 
tion in the animal pole became mottled. When widespread 
cytolysis of the oocytes was observed, these cells were excluded 
from the tally. This phenomenon was particularly frequent in 
the oocytes obtained from frogs that had been primed with in- 
jections of human chorionic gonadotropin. 
H-rusty” ‘* protein was prepared and purified from E. coli 
transformed with the expression plasmid PJCL30 [15] as 
described [16]. Microinjections were performed by injecting 
2550.nl volumes of ras protein diluted to 0.5 or 1 mg/ml in 10 
mM Hepes, pH 7.6, and 1 mM MgCl2. 
3. RESULTS 
Meiotic maturation is standardly assayed by 
scoring the disappearance of the nuclear mem- 
brane, or GVBD in oocytes fixed with 
trichloroacetic acid. In table 1, it can be seen that 
the presence of 20 PM cycloheximide or 500 PM 
puromycin can block completely the GVBD in- 
duced by progesterone or insulin. These concentra- 
tions of the drugs in the medium cause more than 
95% inhibition of protein synthesis in the oocytes 
[17]. In this table it is also shown that the presence 
of the same inhibitors does not significantly 
decrease the GVBD brought about by the microin- 
jection of the activated H-ras’Y” l2 protein. The 5 
experiments presented are representative of more 
than 12 separate experiments that showed essen- 
tially the same results. 
However, some comments are in order with 
respect o the meiotic maturation caused by ras p21 
microinjection. The external morphology of the 
oocytes microinjected with the activated p21 is dif- 
ferent from that of the oocytes treated with hor- 
mone, depending on the amount of the oncogenic 
protein injected and on the hormonal state of the 
animal from which the ovary is obtained. With low 
amounts (- lo-20 ng) of activated ~21, the ap- 
pearance of the white maturation spot on the 
pigmented animal pole is very similar to that 
observed with hormonally induced maturation. 
With higher amounts of the activated ras protein 
(above 30 ng), the pigment of the oocyte becomes 
patchy and 2-3 h after GVBD the cells appear to 
undergo massive cytolysis. With the oocytes 
treated with progesterone, such morphological 
changes occur only 20 h or more after GVBD. The 
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Table 1 
The effect of protein synthesis inhibitors on the induction of oocyte maturation (GVBD) by hormones and microinjection of activated 
H-r&” I2 protein 
Expt Maturation inducer Inhibitor added % oocytes 
undergoing GVBD 
% inhibition 
1 progesterone (10 PM) 
insulin (1 PM) 
H-~uS”‘~ I2 protein (20 ng) 
progesterone (10 PM) 
insulin (1 PM) 
H-ra.srYs I2 protein (20 ng) 
progesterone (10 PM) 
insulin (1 PM) 
H-ra.@ ” protein (28 ng) 
progesterone (10 PM) 
H-ru@ I2 protein (20 ng) 
progesterone (10 PM) 
H-rusty” I2 protein (17 ng) 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
cycloheximide 
puromycin 
puromycin 
100 
0 
100 
0 
91 
95 
100 
0 
100 
0 
86 
76 
100 
0 
100 
0 
67 
55 
94 
0 
70 
87 
100 
0 
95 
81 
100 
100 
0 
100 
100 
12 
100 
100 
18 
100 
0 
100 
15 
Stage VI oocytes were manually separated from ovaries obtained from adult X. laevis previously treated with human chorionic 
gonadotropin [7] and were placed in Barth solution. Groups of 30-35 oocytes were incubated with progesterone or insulin and, where 
indicated, with the simultaneous addition of either 20pM cycloheximide or 500pM puromycin. Separate groups of oocytes were 
microinjected with lo-28 ng ras protein in 30-TO-n1 volumes and incubated either in Barth solution alone or with added inhibitor as 
given. Maturation was scored at 8-10 h and the absence of the nucleus confirmed by dissecting the oocytes fixed in 5% trichloroacetic 
acid. Each experiment was carried out with oocytes from a different animal 
experiments presented in table 1 were performed 
with oocytes from frogs that had been ‘primed’ by 
recurrent injection of low doses (So-100 units) of 
human chorionic gonadotropin [7]. Cells from un- 
treated frogs showed slower kinetics of maturation 
with microinjection of activated ras protein, re- 
quiring up to 10 h to complete GVBD. This 
phenomenon is also well-documented for pro- 
gesterone induction of maturation. 
The presence or absence of K+, which affects the 
maturation response to metal ions [18], did not 
significantly change the induction of maturation 
by ras protein microinjection (not shown). 
Theophylline at 1 mM is a well-known inhibitor 
of CAMP phosphodiesterase and has been shown 
to inhibit the maturation of oocytes induced by 
progesterone, human chorionic gonadotropin and 
lanthanum ion [5]. It was also shown that 1 mM 
theophylline caused an inhibition of 50-60% of 
protein synthesis. Table 2 shows that the presence 
of this drug does result in a partial inhibition of the 
GVBD caused by activated ras protein. In this 
case, it is important to point out that approximate- 
ly half of the nuclear breakdowns scored cor- 
responded to nuclei that had migrated to the 
membrane of the animal pole but had not suffered 
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Table 2 
Effect of theophylline on the meiotic maturation of oocytes (GVBD) caused by hormones and microinjection of activated H-r&’ I2 
protein 
Expt Maturation inducer Inhibitor added % oocytes % inhibition 
undergoing GVBD 
1 progesterone 88 
theophylline 0 100 
H-ru.? I2 protein (10 ng) 47 
theophylline 19” 59 
2 progesterone 83 
theophylline 0 100 
H-r&‘” i2 protein (20 ng) 85 
theophylline 54a 36 
a About half of the oocytes in these groups showed abnormal maturation and the 070 GVBD given includes those oocytes which had 
the typical white spot but in which nuclear material had migrated toward the animal pole and had a flattened funnel shape 
Stage VI oocytes were manually separated from ovaries obtained from adult female X. laevis which had not been primed by previous 
hormone treatment. Incubations and microinjections were carried out as given in table 1. Theophylline was at 1 mM. Maturation was 
scored at 18 h 
complete dispersion of their nuclear contents 
which were funnel-shaped. This result is similar to 
the observations of Birchmeier et al. [12] after 
treatment with cholera toxin of oocytes microin- 
jetted with ras ~21. 
4. DISCUSSION 
The present results clearly demonstrate that the 
induction of oocyte meiotic maturation by micro- 
injection of activated H-rasrys r2 proteins cannot be 
blocked by inhibitors of protein synthesis. This 
finding is important because it provides some in- 
formation regarding the place where ras may be 
operating in the cascade of events that lead to 
meiotic division. Fig. 1 shows the possible sequence 
of events that may participate in oocyte meiotic 
maturation induced by the putative separate path- 
ways of two hormones: progesterone and insulin. 
The progesterone pathway has been well 
documented [l] and some of its most salient 
features are discussed in section 1. It is clear that 
MPF appearance and increased specific protein 
phosphorylation are downstream of the protein 
synthesis requirement in that pathway [8]. 
Insulin maturation has been postulated to 
operate through a different and separate pathway 
and to include ras proteins on the basis of ex- 
periments whereby anti-ras monoclonal antibodies 
block insulin induction of maturation but not the 
process triggered by progesterone [ 13,141. Perti- 
nent to this relationship are the experiments of 
Stacey and co-workers [ 191 that demonstrated that 
ras antibodies block the transforming effects of 
oncogenes that, like insulin, involve membrane 
tyrosine kinase activities. The present work 
demonstrates that protein synthesis is required for 
insulin-induced maturation and that ras action in 
that pathway‘is downstream from the protein syn- 
thesis requirement. This is interesting because it 
separates rus from the primary membrane signal 
transduction mechanism for insulin where it has 
been generally postulated to act [l 11. However, it 
is also clear that ras protein in the oocyte also 
binds to the membrane [12]. 
This observation also makes rus protein similar 
to MPF which appears to be a universal compo- 
nent of dividing cells. An important related obser- 
vation is the recent finding that microinjection of 
activated ras protein into oocytes causes an in- 
crease in specific protein phosphorylation 
(Nebrada, A. et al., submitted). 
The partial inhibition of activated ras-mediated 
oocyte maturation obtained with theophylline is 
not easily interpreted because this drug is known to 
have several effects. The capacity of theophylline 
to inhibit 50-60% of oocyte protein synthesis at 
the concentration used [5] cannot explain the 
decrease of ras-induced maturation because the 
more potent inhibitors of protein synthesis, cyclo- 
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Fig.1. Possible alternative cascades for the induction of am- 
phibian oocyte meiotic maturation by progesterone and insulin. 
Dashed arrows indicate unknown mechanisms that may connect 
different components of the cascade. This speculative scheme 
does not pretend to include all the information about oocyte 
meiotic maturation that is available. 
heximide and puromycin, do not interfere with this 
process. Its effect as an inhibitor of CAMP phos- 
phodiesterase which tends to increase intracellular 
CAMP could be related to the observed effect. This 
possibility is supported by the observation of 
Birchmeier et al. [ 121, who obtained similar partial 
inhibition and atypical nuclear behavior by treat- 
ment of ras-injected oocytes with cholera toxin, a 
protein which also causes an increase in intra- 
cellular CAMP through activation of adenylate 
cyclase. 
Meiotic maturation of oocytes seems to be a 
valid model in which to study some of the factors 
that trigger cell division. It is very convenient that 
the oncogenic mutation that activates the trans- 
forming activity of ras proteins reflects itself in a 
highly increased capacity of these proteins to cause 
oocyte maturation, a process which can also be 
triggered by hormones and which can be studied in 
these cells in the absence of cell growth. 
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